Boston Scientific Corp
(XTER:BSX)
€
86.5
-0.5 (-0.57%)
Market Cap: 126.52 Bil
Enterprise Value: 134.81 Bil
PE Ratio: 74.93
PB Ratio: 6.45
GF Score: 79/100 Boston Scientific Corp at SVB Leerink Global Healthcare (Virtual) Transcript
Feb 17, 2022 / 02:20PM GMT
Release Date Price:
€38.26
(+0.16%)
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior Analyst
Good morning, everyone. Thank you for joining us for day 2 of the company fireside chat for the SVB Leerink Global Healthcare Conference. I am Danielle Antalffy. I'm the med tech analyst here at Leerink, and we are very lucky to have with us Boston Scientific. We have Dan Brennan, CFO; and also Lauren Tengler, Head of Investor Relations. So I will just launch right into Q&A. Dan, if that's okay.
Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO
Sure.
Questions & Answers
Danielle Joy Antalffy
SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior Analyst
So let's start with 2022 guidance, the sense is that it did disappoint some, but you have historically tried to be as conservative as possible. Tell me if I'm wrong in characterizing it that way. But can you talk about your approach to arriving at the 2022 sales growth and EPS guidance
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot